Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.
Saved in:
| Title: | Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine. |
|---|---|
| Authors: | Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Streblow ZJ; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Andoh TF; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Denton M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Raué HP; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Amanna IJ; Najít Technologies, Inc., Beaverton, Oregon, United States of America., Slifka DK; Najít Technologies, Inc., Beaverton, Oregon, United States of America., Kreklywich CN; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Arduino I; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy., Sulgey G; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Streblow MM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Heise MT; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Slifka MK; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Streblow DN; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America. |
| Source: | PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Mar 17; Vol. 19 (3), pp. e0012938. Date of Electronic Publication: 2025 Mar 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40096126 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Weber+WC%22">Weber WC</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Streblow+ZJ%22">Streblow ZJ</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Andoh+TF%22">Andoh TF</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Denton+M%22">Denton M</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Raué+HP%22">Raué HP</searchLink>; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Amanna+IJ%22">Amanna IJ</searchLink>; Najít Technologies, Inc., Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Slifka+DK%22">Slifka DK</searchLink>; Najít Technologies, Inc., Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Kreklywich+CN%22">Kreklywich CN</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Arduino+I%22">Arduino I</searchLink>; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.<br /><searchLink fieldCode="AU" term="%22Sulgey+G%22">Sulgey G</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Streblow+MM%22">Streblow MM</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Heise+MT%22">Heise MT</searchLink>; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Slifka+MK%22">Slifka MK</searchLink>; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Streblow+DN%22">Streblow DN</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101291488%22">PLoS neglected tropical diseases</searchLink> [PLoS Negl Trop Dis] 2025 Mar 17; Vol. 19 (3), pp. e0012938. <i>Date of Electronic Publication: </i>2025 Mar 17 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101291488 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-2735 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219352727%22">19352727 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Negl Trop Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40096126 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pntd.0012938 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0012938 Titles: – TitleFull: Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weber WC – PersonEntity: Name: NameFull: Streblow ZJ – PersonEntity: Name: NameFull: Andoh TF – PersonEntity: Name: NameFull: Denton M – PersonEntity: Name: NameFull: Raué HP – PersonEntity: Name: NameFull: Amanna IJ – PersonEntity: Name: NameFull: Slifka DK – PersonEntity: Name: NameFull: Kreklywich CN – PersonEntity: Name: NameFull: Arduino I – PersonEntity: Name: NameFull: Sulgey G – PersonEntity: Name: NameFull: Streblow MM – PersonEntity: Name: NameFull: Heise MT – PersonEntity: Name: NameFull: Slifka MK – PersonEntity: Name: NameFull: Streblow DN IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 03 Text: 2025 Mar 17 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1935-2735 Numbering: – Type: volume Value: 19 – Type: issue Value: 3 Titles: – TitleFull: PLoS neglected tropical diseases Type: main |
| ResultId | 1 |